While loss of p53 alone results primarily in localized thymic T cell lymphomas, as has been reported before [31], the combined reduction of Separase with loss of p53 results in more widespread B- and T-Cell lymphoma and leukemia with gross involvement of the bone marrow. Here, TP53 is linked to T-cell non-Hodgkin lymphoma.